BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2026.
World J Psychiatry. Jan 19, 2026; 16(1): 110875
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.110875
Table 1 Comparison of general information between the two groups, n (%)
General information
Depression group (n = 42)
Non-occurrence group (n = 58)
Test statistic
P value
Sexχ2 = 0.1030.748
Male24 (57.14)35 (60.34)
Female18 (42.86)23 (39.66)
Age (year), mean ± SD63.26 ± 4.1063.85 ± 4.76t = 0.6480.519
Marital statusχ2 = 0.0770.782
Married37 (88.10)50 (86.21)
Unmarried/divorced/widowed5 (11.90)8 (13.79)
Monthly per capital incomeχ2 = 5.6090.018
≥ 5000 yuan16 (38.10)36 (62.07)
< 5000 yuan26 (61.90)22 (37.93)
Place of residenceχ2 = 0.2010.654
Urban20 (47.62)25 (43.10)
Rural22 (52.38)33 (56.90)
Comorbid hypertensionχ2 = 0.4930.483
Yes12 (28.57)13 (22.41)
No30 (71.43)45 (77.59)
Comorbid diabetesχ2 = 0.0270.870
Yes10 (23.81)13 (22.41)
No32 (76.19)45 (77.59)
Drinking historyχ2 = 0.3130.576
Yes13 (30.95)15 (25.86)
No29 (69.05)43 (74.14)
Smoking historyχ2 = 3.0240.082
Yes11 (26.19)25 (43.10)
No31 (73.81)33 (56.90)
Social supportχ2 = 7.4410.024
Low17 (40.48)11 (18.97)
Medium15 (35.71)20 (34.48)
High10 (23.81)27 (46.55)
Education levelχ2 = 4.6770.031
High school and above14 (33.33)32 (55.17)
Junior high school and below28 (66.67)26 (44.83)
Sleep disorderχ2 = 6.1720.013
Yes25 (59.52)20 (34.48)
No17 (40.48)38 (65.52)
Table 2 Comparison of disease data between the two groups, n (%)
Disease data
Depression group (n = 42)
Non-occurrence group (n = 58)
χ²
P value
Tumor location0.4190.811
Upper segment6 (14.29)10 (17.24)
Middle segment28 (66.67)35 (60.34)
Lower segment8 (19.05)13 (22.41)
Tumor type0.0270.870
Squamous cell carcinoma32 (76.19)45 (77.59)
Adenocarcinoma10 (23.81)13 (22.41)
Surgical treatment0.0390.843
Yes4 (9.52)5 (8.62)
No38 (90.48)53 (91.38)
Number of bone metastases0.2010.654
> 3 lesions22 (52.38)33 (56.90)
≤ 3 lesions20 (47.62)25 (43.10)
Site of bone metastases0.0660.797
Axial bones (pelvis, spine)25 (59.52)36 (62.07)
Peripheral bones17 (40.48)22 (37.93)
Clinical stage0.1640.685
Stage I–II20 (47.62)30 (51.72)
Stage III–IV22 (52.38)28 (48.28)
Skeletal-related events0.0410.839
Yes8 (19.05)12 (20.69)
No34 (80.95)46 (79.31)
Table 3 Comparison of laboratory indicators between the two groups, mean ± SD
Laboratory indicator
Depression group (n = 42)
Non-occurrence group (n = 58)
t value
P value
WBC (× 109/L)3.20 ± 0.343.18 ± 0.390.2670.790
hs-CRP (mg/L)75.33 ± 6.6862.35 ± 7.109.248< 0.001
Total protein (g/L)64.33 ± 5.8764.95 ± 5.290.5520.582
Albumin (g/L)38.02 ± 4.4737.92 ± 4.250.1140.910
Table 4 Description of independent variables
Independent variable
Type
Assignment
Monthly household income per capitalCategorical1: < 5000 yuan
0: ≥ 5000 yuan
Educational levelCategorical1: Junior high school or below
0: High school or above
Social supportCategorical1: High
2: Medium
3: Low
Sleep disorderCategorical1: Yes
0: No
hs-CRPContinuous-
Smoking historyCategorical1: Yes
0: No
Table 5 Logistic regression analysis of risk factors for depression in patients with esophageal cancer and bone metastasis
Variable
B
SE
Wald
P value
OR
95%CI
Constant-20.6612.28581.795< 0.001--
Monthly income per capital0.9780.4175.4910.0192.6591.173-6.026
Educational level0.9010.4214.5880.0322.4621.080-5.613
Social support (low)1.6290.5299.4790.0025.1001.808-14.388
Social support (medium)1.2630.5185.9420.0153.5361.281-9.760
Sleep disorder1.0280.4186.0280.0142.7941.230-6.346
hs-CRP0.2730.05425.848< 0.0011.3141.183-1.460
Smoking history-0.7440.6201.4390.2300.4750.141-1.603